I think the reason they talk about uplist as a potential moving target because partnerships often take longer to negotiate than everyone expects. They can say Q4, but would get annihilated if it fell on Jan 1 2015. I believe Lympro partner is one of the main milestones and there is a lot to that milestone.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links